LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: The FLAME study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Respiratory Journal

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/13993003.CONGRESS-2016.OA4833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Pharmacological treatment of COPD - New evidence.

  2019influential citation
• EVIEW harmacological treatment of COPD-- New evidence

  2019cites this paper